ARS Pharmaceuticals Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
ARS Pharmaceuticals Inc.
Former names
Silverback Therapeutics, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SPRY
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001671858
EIN
81-1489190
Wikidata ID
Q87556967

Board of directors

Follow this board

Chief executives

Richard E. Lowenthal · President and CEO
Dates unknown
Donn Casale · President and CEO
Dates unknown

Director election results

Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 33 other boards. 33 are in the same sector.

Network of ARS Pharmaceuticals Inc.'s board connections Sionna Therapeutics Inc. Sionna Therapeutics In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bambusa Therapeutics Inc. Bambusa Therapeutics I... Bicara Therapeutics Inc. Bicara Therapeutics In... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Climb Bio Inc. Climb Bio Inc. Evommune Inc. Evommune Inc. Freenome Inc. Freenome Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Mineralys Therapeutics Inc. Mineralys Therapeutics... Nkarta Inc. Nkarta Inc. Peter A. Thompson Peter A. Thompson Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah ARS Pharmaceuticals Inc.
Shared director Other board Same sector +17 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$1,949,299
5 sales by 4 insiders
Date Insider Transaction Shares Price Value
Jun 12, 2026 Karas Eric Officer (Chief Commercial Officer) Option exercise +25,000 $1.50 $37,500
Jun 12, 2026 Fitzpatrick Alexander A Officer (Chief Legal Officer) Open-market sale −3,355 $10.00 $33,550
Jun 12, 2026 Karas Eric Officer (Chief Commercial Officer) Open-market sale −25,000 $10.00 $250,000
Nov 13, 2025 Dorsey Brian Officer (Chief Operating Officer) Option exercise +21,828 $0.64 $13,970
Nov 13, 2025 Dorsey Brian Officer (Chief Operating Officer) Open-market sale −21,828 $8.71 $190,122
Nov 12, 2025 Chakma Justin Officer (Chief Business Officer) Option exercise +30,000 $0.84 $25,200
Nov 12, 2025 Pratik Shah Director Gift −250,000 — —
Nov 12, 2025 Chakma Justin Officer (Chief Business Officer) Open-market sale −30,000 $8.91 $267,300
Nov 12, 2025 Pratik Shah Director Gift −100,000 — —
Nov 12, 2025 Chakma Justin Officer (Chief Business Officer) Open-market sale −136,380 $8.86 $1,208,327
Aug 21, 2025 Richard E. Lowenthal Director, Officer (PRESIDENT AND CEO), 10% owner Open-market sale −50,000 $14.49 $724,500
Aug 21, 2025 Kathleen D. Scott Officer (Chief Financial Officer) Option exercise +12,500 $1.50 $18,750
Aug 21, 2025 Kathleen D. Scott Officer (Chief Financial Officer) Open-market sale −12,500 $15.00 $187,500
Aug 20, 2025 Tanimoto Sarina Officer (CHIEF MEDICAL OFFICER), 10% owner Open-market sale −37,656 $14.09 $530,573
Aug 19, 2025 Tanimoto Sarina Officer (CHIEF MEDICAL OFFICER), 10% owner Open-market sale −12,344 $14.03 $173,186

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States

Questions about ARS Pharmaceuticals Inc.

Who is the CEO of ARS Pharmaceuticals Inc.?

Richard E. Lowenthal is ARS Pharmaceuticals Inc.'s President and CEO.

How many directors are on ARS Pharmaceuticals Inc.'s board?

ARS Pharmaceuticals Inc.'s board has 12 directors: Brent L. Saunders, Donn Casale, Laura Shawver, Michael Kelly, Peter A. Thompson, Peter Kolchinsky, Phillip M. Schneider, Pratik Shah, Rajeev Dadoo, Rajeev M. Shah and 2 others.

Are ARS Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, ARS Pharmaceuticals Inc. insiders made no open-market purchases and sold $1.9 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is ARS Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="ars-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.